Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Frontline”

239 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 239 results

Early research (Phase 1)Looking for participantsNCT06696768
What this trial is testing

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8+1 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT03234335
What this trial is testing

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal Failure
Centre Hospitalier Universitaire de Saint Etienne 50
Testing effectiveness (Phase 2)Looking for participantsNCT06160791
What this trial is testing

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Who this might be right for
Hemophagocytic Lymphohistiocytoses
Jerry Lee, MD, MSc, MPhil 54
Not applicableStudy completedNCT04460768
What this trial is testing

An INternational Frontline Ovarian Cancer Real World Management Study

Who this might be right for
Ovarian Neoplasms
AstraZeneca 989
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264
What this trial is testing

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 218
Testing effectiveness (Phase 2)UnknownNCT02834286
What this trial is testing

Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Hospital Universitario Dr. Jose E. Gonzalez 15
Large-scale testing (Phase 3)Looking for participantsNCT07383441
What this trial is testing

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
SWOG Cancer Research Network 718
Very early researchEnded earlyNCT04368676
What this trial is testing

Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic

Who this might be right for
Job StressWorkplace StressCompassion Fatigue+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04934475
What this trial is testing

MInimal Residual Disease Adapted Strategy

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 791
Early research (Phase 1)Looking for participantsNCT06313437
What this trial is testing

Revumenib in Combination With 7+3 + Midostaurin in AML

Who this might be right for
Acute Myeloid LeukemiaAML, AdultAML With Gene Mutations+2 more
Richard Stone, MD 22
Testing effectiveness (Phase 2)Study completedNCT02572167
What this trial is testing

Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 93
Testing effectiveness (Phase 2)WithdrawnNCT00967512
What this trial is testing

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Who this might be right for
Acute Myelogenous Leukemia
Eleos, Inc.
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01206205
What this trial is testing

Frontline Therapy in de Novo Multiple Myeloma Patients Under 65

Who this might be right for
Multiple Myeloma
University Hospital, Toulouse 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517705
What this trial is testing

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Nebraska 50
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Testing effectiveness (Phase 2)Looking for participantsNCT02877303
What this trial is testing

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma
M.D. Anderson Cancer Center 80
Large-scale testing (Phase 3)Study completedNCT01712490
What this trial is testing

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Takeda 1,334
Large-scale testing (Phase 3)Study completedNCT00866203
What this trial is testing

HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy

Who this might be right for
High-Grade Lymphomas
Gruppo Italiano Studio Linfomi 441
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Next Page